SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma

Letouzé, Eric, Martinelli, Cosimo, Loriot, Céline, Burnichon, Nelly, Abermil, Nasséra, Ottolenghi, Chris, Janin, Maxime, Menara, Mélanie, Nguyen, An Thach, Benit, Paule, Buffet, Alexandre, Marcaillou, Charles, Bertherat, Jérôme, Amar, Laurence, Rustin, Pierre, De Reyniès, Aurélien, Gimenez-Roqueplo, Anne-Paule, Favier, Judith·2013·Cancer Cell

Cited by (813)

Items 601–700 of 813

  1. Characterisation of an Adult Zebrafish Model for SDHB-Associated Phaeochromocytomas and Paragangliomas
    Jasmijn B. Miltenburg, Marnix Gorissen, Inge van Outersterp, Iris Versteeg, Alex Nowak, Richard J. Rodenburg, Antonius Eduard van Herwaarden, André J. Olthaar, Benno Küsters, Catleen Conrad et al. · 2024 · International Journal of Molecular Sciences
  2. A rare case of a 65 year old female with a mesenteric paraganglioma
    Raffaele Rocco, Brittany L. Murphy, Vatsal P. Patel, Oksana Hamidi, Alice Y. Chang, Melanie L. Lyden · 2019 · Human Pathology Case Reports
  3. A bittersweet symphony
    Adrian Daly, Albert M. Beckers · 2014 · Endocrine Related Cancer
  4. Acute myeloid leukemia therapy elicits durable complete response in chemoradio‐resistant metastatic paraganglioma
    Sameer Farouk Sait, Rachel Kobos, Michael P. LaQuaglia, Neeta D. Pandit-Taskar, Shakeel I. Modak · 2016 · Pediatric Blood & Cancer
  5. DNA Methylation Changes in Cancer
    John P. Thomson, Richard R. Meehan · 2017 · Cancer drug discovery and develogment/Cancer drug discovery and development
  6. Misregulation of DNA Methylation Regulators in Cancer
    Joyce J. Thompson, Keith D. Robertson · 2017 · Cancer drug discovery and develogment/Cancer drug discovery and development
  7. Pathologies liées aux déficits du cycle de Krebs
    Paule Bénit, Sylvie Bortoli, Dominique Chrétien, Malgorzata Rak, Pierre Rustin · 2018 · Revue Francophone des Laboratoires
  8. SDHB and SDHA Immunohistochemistry in Canine Pheochromocytomas
    Firas Mohammed Abed, Melissa A. Brown, Omar Ahmed Al-Mahmood, Michael J. Dark · 2020 · Animals
  9. Pheochromocytoma and Paraganglioma
    Mercedes Robledo, María Currás, Alberto Cascón · 2021 · Springer eBooks
  10. Lack of Major Genome-Wide DNA Methylation Changes in Succinate-Treated Human Epithelial Cells
    Wei Cui, Zhijun Huang, Gerd P. Pfeifer · 2022 · International Journal of Molecular Sciences
  11. Les xénobiotiques, quel impact sur les maladies métaboliques ?
    Laurence Therese HUC, Sylvie Bortoli, Xavier Coumoul · 2019 · Cahiers de Nutrition et de Diététique
  12. Protein Hyperacylation Links Mitochondrial Dysfunction with Nuclear Organization
    John A. Smestad, Micah J. McCauley, Matthew Amato, Yuning Xiong, Juan Liu, Yi-Cheng Sin, Jake Ellingson, Yue Chen, Fatimah J. Al Khazal, Brandon A. Wilbanks et al. · 2020 · SSRN Electronic Journal
  13. Towards decoding the coupled decision-making of metabolism and epithelial-mesenchymal transition in cancer
    Dongya Jia, Jun Hyoung Park, Harsimran Kaur, Kwang Hwa Jung, Sukjin Yang, Shubham Tripathi, Madeline Galbraith, Youyuan Deng, Mohit Kumar Jolly, Benny Abraham Kaipparettu et al. · 2020 · arXiv (Cornell University)
  14. Illuminating histidine phosphorylation in the pancreatic tumor microenvironment
    Natalie Luhtala, Nikki K. Lytle, Kathleen E. DelGiorno, Yu Shi, Razia F. Naeem, Michael Anthony Hollingsworth, Susan M. Kaech, Geoffrey M. Wahl, Tony R. Hunter · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  15. Hereditary leiomyomatosis and renal cell cancer (HLRCC), pheochromocytoma (PCC)/paraganglioma (PGL) and germline fumarate hydratase (FH) variants
    John J. Orrego, Joseph A. Chorny · 2024 · Endocrinology Diabetes and Metabolism Case Reports
  16. Metabolic Effects of the Cancer Metastasis Modulator MEMO1
    Marziyeh Ghanbarian, Natalia V. Dolgova, Frederick S. Vizeacoumar, Franco J. Vizeacoumar, Deborah L. Michel, Anas El‐Aneed, Oleg Y. Dmitriev · 2025 · Metabolites
  17. Carcinogenesis trajectories
    Rui Wang, Zhaopeng Yan · 2025 · Frontiers in Cell and Developmental Biology
  18. Prokaryotic organelle mitochondria drive tumorigenesis: “the original sin”
    Chaoyi Wang, Ming Luo, Jinhui Zhou, Qihao Zhang, Ji Xiawei, Jiayao He, Lingfei Wang, Yingpeng Huang, Xue Xu, 王方岩 · 2026 · Frontiers in Oncology
  19. α-ketoglutarate/succinate ratio imbalance impairs thymine DNA glycosylase function and base excision repair process increasing susceptibility to pancreatic cancer
    Silvia Malatesta, Virginia Vigiano Benedetti, Emanuela Salviati, Barbara Illi, Isabella Manni, Emanuele Middonti, Gian Luca Rampioni Vinciguerra, Valerio Licursi, Francesca Troilo, Gianni Colotti et al. · 2026 · Cell Death and Disease
  20. Context-dependent synthetic lethality — an emerging precision therapeutic approach
    Liang Chang, Katharin L. Shaw, Francisca Vázquez, William R. Sellers · 2026 · Nature reviews. Cancer
  21. Management of Locally Advanced and Metastatic Pheochromocytoma and Paraganglioma
    Alejandro Román-Gonzaléz, Paola Jiménez Vásquez, Samuel M. Hyde, Aaron Jessop, Camilo Jiménez · 2016 · Springer eBooks
  22. Pheochromocytoma/Paraganglioma: Update on Diagnosis and Management
    Ivana Jochmanová, Karel Pacák · 2017 · Contemporary Endocrinology
  23. Metabolic Deregulations Affecting Chromatin Architecture: One-Carbon Metabolism and Krebs Cycle Impact Histone Methylation
    Francisco Saavedra, Ekaterina Boyarchuk, Francisca Alvarez, Geneviève Almouzni, Alejandra Loyola · 2019 · RNA technologies
  24. Role of succinate dehydrogenase in hepatocellular carcinoma
    Gowru Srivani, Mohammad Imran, Neha Merchant, Jyothi Priya Mandala, Ganji Purnachandra Nagaraju · 2022 · Elsevier eBooks
  25. A big picture of the mitochondria-mediated signals: From mitochondria to organism
    Neşe Vardar Acar, Rıza Köksal Özgül · 2023 · Biochemical and Biophysical Research Communications
  26. Pheochromocytoma and Paraganglioma
    Eleonora P.M. Corssmit, Leonie Theresia van Hulsteijn · 2024 · Springer eBooks
  27. PBK as a Potential Biomarker and Therapeutic Target for Metastatic Pheochromocytomas and Paragangliomas
    Yue Zhou, Wenqian Zhang, Yunying Cui, Tianyi Li, Zewen Li, Anli Tong · 2025 · The Journal of Clinical Endocrinology & Metabolism
  28. MYC Regulation of Metabolism and Cancer
    Arvin M. Gouw, Annie Lee Hsieh, Zachary E. Stine, Chi Van Dang · 2015 · Springer eBooks
  29. Pheochromocytoma in a Twelve-Year-Old Girl with SDHB-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome
    Daryl Graham, Megan Gooch, Zhan Ye, Edward J. Richer, Aftab S. Chishti, Elizabeth A. Reilly, John August D'Orazio · 2014 · Case Reports in Genetics
  30. Models of Pheochromocytoma: What’s on the Horizon?
    Arthur S. Tischler, Judith Favier · 2015 · International Journal of Endocrine Oncology
  31. Successful induction therapy with sequential CVD followed by high-dose lanreotide in for metastatic SDHB paraganglioma: Case report
    Isabel Tena, José Luis Ponce, Marcos Tajahuerce, Jose Luis Vercher-Conejero, Manuel Cifrián, Katherine I. Wolf, Marcela Miret, María Isabel Del Olmo-García, Rosa Reboll, Antonio Jose Conde-Moreno et al. · 2017 · Journal of Clinical and Translational Endocrinology Case Reports
  32. Setting Up a Laboratory
    Loren J. Joseph · 2015 · Elsevier eBooks
  33. Repair of retrohepatic inferior vena cava injury.
    Ahmed Khan Chaudhry, Muhammad Azam, Rasikh Maqsood · 2003 · PubMed
  34. Pathology of Pheochromocytoma and Paraganglioma
    John Turchini, Anthony James Gill, Arthur S. Tischler · 2018 · Contemporary Endocrinology
  35. Neuroendocrine Neoplasms
    Jim Smith, Edward Barnett, Euan James Rodger, Aniruddha Chatterjee, Rathan M. Subramaniam · 2023 · PET Clinics
  36. Genetic Alterations in Pheochromocytoma and Paraganglioma
    Jenny Welander · 2015 · Linköping University medical dissertations
  37. Targeting Histone Methylation
    Marco P. Licciardello, Stefan Kubicek · 2016 · Elsevier eBooks
  38. The noradrenergic profile of plasma metanephrine in neuroblastoma patients is reproduced in xenograft mice models and arise from PNMT downregulation
    Karim Abid, Maja Beck Popovic, Katia Balmas Bourloud, Jacqueline Schoumans, Joana Grand-Guillaume, Eric Grouzmann, Annick Mühlethaler‐Mottet · 2021 · Oncotarget
  39. Cancer Metabolism
    Natalya N. Pavlova, Craig B. Thompson · 2016 · Wiley eBooks
  40. Mutant IDH silences GSX2 to reprogram neural progenitor cell fate and promote gliomagenesis
    Yi Xiao, Diana D. Shi, Lei Guo, Ethan Neumann, Michael M. Levitt, Pranita Kaphle, Tracey E. Shipman, Haocheng Li, Feng Cai, Denise M. O. Ramirez et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  41. The 3PAs syndrome and succinate dehydrogenase deficiency in pituitary tumors
    Paraskevi Xekouki, Vasiliki N. Daraki, Grigoria Betsi, Maria Chrysoulaki, Maria Sfakiotaki, Maria G. Mytilinaiou, Constantine A. Stratakis · 2021 · Elsevier eBooks
  42. Composite paraganglioma-ganglioneuroma with atypical catecholamine profile and phenylethanolamine N-methyltransferase expression: a case report and literature review
    Yuriko Sasaki, Maki Kanzawa, Masaaki Yamamoto, Keitaro Kanie, Hironori Bando, Kei Yoshino, Yushi Hirota, Katsumi Shigemura, Masato Fujisawa, Wataru Ogawa et al. · 2023 · Endocrine Journal
  43. Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications
    Paraskevi Xekouki, Vasiliki Venetsanaki, Georgios Kyriakopoulos, Krystallenia Alexandraki, Anna G. Angelousi, Gregory Kaltsas · 2024 · Endocrine Reviews
  44. A Mathematical Exploration of SDH-b Loss in Chromaffin Cells
    Elías Vera-Sigüenza, Himani Rana, Ramin Nashebi, Ielyaas Cloete, Katarína Kl’uvčková, Fabian Spill, Daniel A. Tennant · 2025 · Bulletin of Mathematical Biology
  45. PGL-EXPO feasibility study of exposure to SDHi fungicides and risk of hereditary SDHx paraganglioma or pheochromocytoma
    Astrid Coste, Alexandre Buffet, Margaux Duboeuf, Sabrina Boudif, Lény Grassot, Boutheina Ouelaa, Annabelle Sueur, Timgad Lounis, Olivia Pérol, Béatrice Fervers et al. · 2025 · Scientific Reports
  46. A metabolic–epigenetic switch governs multicellular cardiac repair following succinate dehydrogenase inhibition
    Yi Fan, Dakota J. Nuttall, Yi Zhao, Dina Abbasian, Clarissa A. Shoffler, Christopher J. Petucci, Wyatt G. Paltzer, Yu-Ling Chang, James Marchant, Diana Presas-Ramos et al. · 2026 · Nature Cardiovascular Research
  47. Metastatic progression of pheochromocytoma and paraganglioma occurs via parallel evolution
    Andrew Marcel Pregnall, Bradley Stephen Wubbenhorst, Kurt D’Andrea, John B. Pluta, Wajid Amjad, Jake S. Shilan, Debbie L. Cohen, Benita Weathers, Bonita Bennett, Maria Bonanni et al. · 2026 · npj Precision Oncology
  48. Succinate dehydrogenase-deficient cancer cells have increased susceptibility to Ym155-induced DNA damage
    Qianjin Guo, Sooyeon Lee, N. Armstrong, Brian Lim, Rebecca C. Schugar, David Tomz, Haixia Xu, Anzel Zhen, Leor Needleman, Electron Kebebew et al. · 2026 · Endocrine Related Cancer
  49. The Complex Role of Methylation in Regulating Vascular Smooth Muscle Cell Phenotypic States in Vascular Remodeling and Atherosclerosis
    Sanjana C. Basak, Delphine A Gomez · 2026 · Biomolecules
  50. The Role of the Surgical Pathologist in the Recognition of Hereditary SDH-Deficient Tumor Syndromes
    C. Christofer Juhlin, Özgür Mete · 2026 · Advances in Anatomic Pathology
  51. Epigenetic links to the web of Krebs
    Darren J. Burgess · 2013 · Nature reviews. Cancer
  52. Mechanisms of Arsenic Toxicity in Humans: Interplay of Arsenic, Glutathione, and DNA Methylation in Bangladeshi Adults
    Megan M. Niedzwiecki · 2014
  53. Exome sequencing and SDH (A, B) immunohistochemistry of canine Pheochromocytomas
    Firas Mohammed Abed, Michael James Dark · 2022 · Al-mağallaẗ al-ʻirāqiyyaẗ li-l-ʻulūm al-bayṭariyyaẗ/Iraqi journal of veterinary sciences
  54. Succinate dehydrogenase variants in paraganglioma: why are B subunit variants ‘bad’?
    Lucinda Gruber, Steven N. Hart, Louis James Maher III · 2023 · Endocrine Oncology
  55. SDHx mutations are associated with the PI3K-Akt signaling pathway in vagal paragangliomas
    Anastasiya V. Snezhkina, Maria Fedorova, Asiya F. Ayupova, Elena A. Pudova, Anastasiya A. Kobelyatskaya, Dmitry Valerievich Kalinin, Alexander Leonidovich Golovyuk, George Sergeevich Krasnov, Vladislav Pavlov, Anna V. Kudryavtseva · 2023 · Archive of oncology
  56. Mitochondrial Energy Metabolism in Carcinogenesis
    Natalia Kurhaluk, Halina Tkaczenko · 2024 · Interdisciplinary cancer research
  57. Metastatic Malignant Paraganglioma of Rare Sites Failed on Conventional Treatments Demonstrating Beneficial Response to 177Lu-DOTATATE PRRT
    Yeshwanth Edamadaka, Munita Meenu Bal, Swapnil Ulhas Rane, Rahul Vithalrao Parghane, Sandip Kanti Basu · 2024 · World Journal of Nuclear Medicine
  58. Advances and insights in cancer metabolism and epigenetic reprogramming
    Yirong Zeng, Pu Wang, Dan Ye · 2025 · Chinese Science Bulletin (Chinese Version)
  59. Approaches to reduce succinate accumulation by restoration of succinate dehydrogenase activity in cultured adrenal cells
    Fatimah J. Al Khazal, Leili Rahimi, Fan Feng, Nicole A. Becker, Clifford D.L. Folmes, Judith Favier, Louis James Maher III · 2025 · Journal of Cell Science
  60. Radionuclide Imaging of Pheochromocytoma and Paraganglioma in the Era of Multi-omics
    Henri J L M Timmers · 2016 · Springer eBooks
  61. The epigenomic impact of methylation in metabolic dysfunction and cancer
    Cynthia A. Zahnow · 2019 · Elsevier eBooks
  62. Role of microenvironment on neuroblastoma SK-N-AS SDHB silenced cell metabolism and function
    Elena Rapizzi, Rossella Fucci, Elisa Giannoni, Letizia Canu, Susan Richter, Paolo Cirri, Massimo Mannelli · 2015 · Endocrine Abstracts
  63. Tumors of the adrenal glands : genetic and diagnostic aspects
    Fredrika Svahn · 2020 · Figshare
  64. Patient-derived xenograft studies of fumarate hydratase (FH)-deficient uterine leiomyoma subtype
    Takuya Kajimura, Vanida Ann Serna, Emma G Amurgis, Michael L. Blumenfeld, Takeshi Kurita · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  65. Distinct proteomic and acylproteomic adaptations to succinate dehydrogenase loss in two cell contexts
    Sherry X. Zhou, Benjamin J. Madden, Cristine M. Charlesworth, Taro Hitosugi, Judith Favier, Louis James Maher III · 2026 · Journal of Biological Chemistry
  66. Mutations de gènes impliqués dans le métabolisme énergétique et cancer
    Constance Thibault, Anne‐Paule Gimenez‐Roqueplo · 2013 · ONCOLOGIE
  67. Mitochondrial Complex II in Cancer
    Katarína Kľučková, Jiřı́ Neužil, Jakub Rohlena · 2014 · Springer eBooks
  68. Mitochondria : a target for anticancer therapy
    Björn Kruspig · 2014 · Figshare
  69. Succinate Dehydrogenase Deficiency in Sporadic Pituitary Adenomas: A Potential Mechanism for Tumorigenesis
    E.L. Andrews, Stacey K. Mardekian, Markku Miettinen, Mark T. Curtis · 2014
  70. Genetics of Pheochromocytoma
    Victoria L. Martucci, Karel Pacák · 2014 · Wiley eBooks
  71. Mutations de la succinate déshydrogénase et méthylation de l’ADN
    Judith Favier, Éric Letouzé · 2013 · médecine/sciences
  72. Genetic and molecular background of pheochromocytoma and paraganglioma
    Adam Stenman · 2015 · Figshare
  73. Addressing the Core of Carcinogenesis: How a Mitochondrial Mutation Leads to Metabolic Remodeling in Familial Cancers
    Antonio DE FLORA, Silvio De Flora · 2015 · JNCI Journal of the National Cancer Institute
  74. MEN以外の家族性副腎髄質腫瘍 : Pheochromocytoma/Paragangliomaと遺伝子異常 (特集 多発性内分泌腫瘍症(MEN)以外の家族性内分泌外科疾患)
    一博 竹越 · 2015 · 日本内分泌・甲状腺外科学会雑誌
  75. Revue des travaux menés par le programme cartes d’identité des tumeurs sur les tumeurs endocrines : impacts sur la pathologie et la prise en charge des patients
    Aurélien de Reyniès · 2016 · Annales d Endocrinologie
  76. Molecular characterisation of renal cell carcinoma and related disorders
    Mariam Jafri · 2016 · University of Birmingham Institutional Research Archive (University of Birmingham)
  77. Tumor Metabolism and Metabolomics of Pheochromocytomas and Paragangliomas
    Susan Richter, Graeme Eisenhofer · 2016 · Springer eBooks
  78. Molecular Genetics of Pheochromocytoma and Paraganglioma
    Mercedes Robledo, María Currás-Freixes, Alberto Cascón · 2016 · Springer eBooks
  79. Radionuclide Imaging of Head and Neck Paragangliomas
    David Taïeb, Arthur Damien Varoquaux, Ingo Janssen, Karel Pacák · 2016 · Springer eBooks
  80. Elucidating The Role of MifS-MifR Two-Component System in Regulating Pseudomonas aeruginosa Pathogenicity
    Gorakh Tatke · 2016
  81. Metabolic Feedback Control through H3K4 Demethylation
    Maria Soloveychik · 2016 · TSpace (University of Toronto)
  82. Energy Metabolism and Epigenetics
    Scott J. Bultman · 2017 · Springer eBooks
  83. Pheochromocytomas and Paragangliomas: Genetics and Pathophysiology
    Lauren Michelle Fishbein · 2017 · Contemporary Endocrinology
  84. Paroxysmal Hypertension: Pheochromocytoma
    Graeme Eisenhofer, Jacques W.M. Lenders · 2017 · Updates in hypertension and cardiovascular protection
  85. Hereditary paraganglioma : genetics and tumor biology
    Attje S. Hoekstra · 2017 · Leiden Repository (Leiden University)
  86. Pheochromocytoma/Paraganglioma: Management, Genetics, and Follow-up
    Anne‐Paule Gimenez‐Roqueplo, Laurence Amar · 2018 · Elsevier eBooks
  87. Biomarkers in pheochromocytomas and paragangliomas
    Helena Leijon · 2018 · Työväentutkimus Vuosikirja
  88. Feocromocitoma asociado a leiomiomatosis cutánea y uterina y cáncer renal en un paciente con una mutación germinal en el gen de la fumarato hidratasa
    Marta Morón, Juan Luis Afonso, Mauro Boronat · 2019 · Endocrinología Diabetes y Nutrición
  89. Metabolite-Sensing and Human Diseases
    Shimin Zhao, Jian‐Yuan Zhao · 2016 · Scientia Sinica Vitae
  90. 40-Year Follow-Up of a Patient with Multiple Paragangliomas and a SDHD Mutation
    Atanaska P. Elenkova · 2019 · Acta Endocrinologica (Bucharest)
  91. Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma
    Laurène Ben Aim, Pascal Pigny, Luis Jaime Castro‐Vega, Alexandre Buffet, Laurence Amar, Jerome Yves Bertherat, D. Drui, Isabelle Guilhem, Éric Baudin, Charlotte Lussey‐Lepoutre et al. · 2019 · Yearbook of pediatric endocrinology
  92. Pheochromocytoma associated with cutaneous and uterine leiomyomatosis and renal cancer in a patient with a germline mutation in the fumarate hydratase gene
    Marta Morón, Juan Luis Afonso, Mauro Boronat · 2020 · Endocrinología Diabetes y Nutrición (English ed )
  93. Mutations de gènes impliqués dans le métabolisme énergétique et cancer Genetic mutations involved in energy metabolism and cancer
    Constance Thibault · 2013
  94. Familial Paraganglioma Pheochromocytoma Syndrome, SDH Related
    Vânia Nosé · 2018 · Elsevier eBooks
  95. Metastatic Paragangliomas and Pheochromocytomas: An Epigenetic View
    María‐Dolores Chiara, Lucía Celada, Andrés San José Martínez, Tamara Cubiella, Enol Álvarez-González, Nuria Valdés · 2021 · IntechOpen eBooks
  96. Succinate Dehydrogenase Mutation and Paraganglioma Syndromes: A Review Article
    Pooja Ramakant · 2021 · Indian Journal of Endocrine Surgery and Research
  97. A chemical screen for suppressors of dioxygenase inhibition in a yeast model of familial paraganglioma
    William F. Beimers, Megan M. Braun, Kaleb Schwinefus, Keenan S. Pearson, Brandon A. Wilbanks, Louis James Maher III · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  98. Selección de poemas inéditos conservados en el Archivo Juan Gil-Albert de la Biblioteca Valenciana
    Pilar Escobedo Cubells, Juan Francisco Morales Ferrer · 2004 · Laberintos: revista de estudios sobre los exilios culturales españoles
  99. Aggiornamenti sulla prima fase di Capua
    Werner Johannowsky · 2025 · Annali di archeologia e storia antica
  100. Succinate Uptake by T Cells Suppresses Their Anti-Tumour Function Via Inhibition of Mitochondrial Glucose Oxidation
    Nancy H. Gudgeon, Haydn Munford, Emma L. Bishop, James Hill, Taylor Fulton-Ward, David Bending, Jennie Roberts, Daniel A. Tennant, Sarah Dimeloe · 2021 · SSRN Electronic Journal